Rhythm Pharmaceuticals, Inc.
- Stock
- Ticker RYTM
- ISIN US76243J1051
- Nasdaq
Performance, volatility and drawdowns of Rhythm Pharmaceuticals, Inc. since 10/2017, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $97,619. Global equities (VT): $14,653.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −92.1% in 05/2022, measured from the peak in 01/2021. It took 35 months to get back to the old peak.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 42 | 33 | 49 | 51 | 57 | 60 | 71 | 92 |
| Gross profit | 38 | 29 | 43 | 46 | 52 | 53 | 62 | 80 |
| Operating income | -41 | -47 | -45 | -53 | -47 | -52 | -49 | -39 |
| Net income | -43 | -49 | -47 | -53 | -48 | -56 | -49 | -41 |
| Earnings per share | -0.72 | -0.81 | -0.75 | -0.82 | -0.73 | -0.83 | -0.73 | -0.61 |
| Balance sheet | ||||||||
| Total assets | 392 | 387 | 373 | 507 | 480 | 442 | 437 | 443 |
| Liabilities | 228 | 224 | 239 | 211 | 210 | 205 | 220 | 242 |
| Equity | 22 | 19 | -12 | 149 | 139 | 123 | 103 | 88 |
| Cash | 89 | 106 | 136 | 52 | 54 | 62 | 66 | 40 |
| Long-term debt | 108 | 108 | 106 | 103 | 101 | 98 | 93 | 88 |
| Cash flow | ||||||||
| Operating cash flow | -19 | -40 | -23 | -27 | -25 | -44 | -9.2 | -3.1 |
| Capital expenditure | – | – | – | – | -1.0 | – | – | – |
| Free cash flow | -19 | -40 | -23 | -27 | -26 | -44 | -9.2 | -3.1 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2022 at +191.8%, weakest 2021 at −66.4%. 5 of 8 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 3 Nov 2026 | −$0.61 |
| 4 Aug 2026 | −$0.73 |
| 5 May 2026 | −$0.83 |
| 26 Feb 2026 | −$0.73 |
| 4 Nov 2025 | −$0.82 |
| 5 Aug 2025 | −$0.75 |
| 7 May 2025 | −$0.81 |
| 28 Feb 2025 | −$0.72 |
| 6 Nov 2024 | −$0.73 |
| 6 Aug 2024 | −$0.55 |
| 7 May 2024 | −$2.35 |
| 29 Feb 2024 | −$0.70 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €7.1bn
- Market cap in trading currency
- $7.79bn
- Enterprise value
- $7.57bn
- P/E
- –
- P/S
- 27.75
- P/B
- 88.56
- EV/Sales
- 26.97
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- -1.0%
Results (last four quarters)
- Revenue
- $281m
- Gross profit
- $248m
- EBITDA
- –
- Net income
- −$194m
- Earnings per share
- −$2.90
- Revenue per share
- $4.05
- Revenue growth
- +79.6%
- Earnings growth
- –
Profitability
- Gross margin
- 88.2%
- Operating margin
- -66.7%
- Net margin
- -69.0%
- Return on equity
- -163.7%
- Return on assets
- -43.7%
Balance sheet and cash flow
- Cash
- $321m
- Cash per share
- $4.63
- Financial debt
- $103m
- Debt/equity %
- 117
- Current ratio
- 2.78
- Book value per share
- $1.27
- Operating cash flow
- −$81.8m
- Free cash flow
- −$81.8m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 69.3m
- Volume
- 1.50m
- Avg. volume 3 months
- 1.02m
- Relative volume
- 1.4
Price and technicals
- Price
- $112.36
- 1 day
- −3.8%
- 52-week high
- $119.04
- 52-week low
- $75.82
- Distance to 52-week high
- −5.6%
- Distance to 52-week low
- +48.2%
- Distance to 50-day line
- +14.6%
- Distance to 200-day line
- +15.3%
- RSI (14)
- 57
- Volatility 1M
- 106.7%
Performance
- 1 week
- −2.3%
- 1 month
- +23.6%
- 3 months
- +0.8%
- 6 months
- +27.9%
- YTD
- +5.0%
- 1 year
- +8.9%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has RYTM performed since 10/2017?
$10,000 grew to $37,453 by 20 Nov 2026, which is +15.6% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is RYTM?
Volatility was 94.8% per year, measured on monthly returns. The largest decline from a peak was −92.1%, with the low in 05/2022.
How does RYTM compare with a broad equity ETF?
Over the same period Global equities (VT) returned +10.0% per year at 15.8% volatility, RYTM returned +15.6% at 94.8%. The correlation of monthly returns was 0.24; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.